(Reuters) – Moderna Inc said on Thursday that contract manufacturer Recipharm had begun making the company’s COVID-19 vaccine at its manufacturing site in France after gaining approval from Europe’s drugs regulator.
(Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)
